Showing results (21-30 of 38) with videos related to
Sort By:
Pageof 4
Journal of the American Heart Association|January 28, 2015
Pharmacogenomics of hypertension: a genome‐wide, placebo‐controlled cross‐over study, using four classes of antihypertensive drugsTimo P Hiltunen, Kati M Donner, Antti-Pekka Sarin, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|November 27, 2013
Genetic burden of common variants in progressive and bout-onset multiple sclerosisMelissa Sorosina, Paola Brambilla, Ferdinando Clarelli, et al.Trials|January 18, 2011
Main results of the ouabain and adducin for Specific Intervention on Sodium in Hypertension Trial (OASIS-HT): a randomized placebo-controlled phase-2 dose-finding study of rostafuroxinJan A Staessen, Lutgarde Thijs, Katarzyna Stolarz-Skrzypek, et al.Journal of the American Heart Association|August 20, 2019
Genome-Wide Meta-Analysis of Blood Pressure Response to β1-Blockers: Results From ICAPS (International Consortium of Antihypertensive Pharmacogenomics Studies)Sonal Singh, Helen R Warren, Timo P Hiltunen, et al.Hypertension (Dallas, Tex. : 1979)|November 2, 2016
Genome-Wide and Gene-Based Meta-Analyses Identify Novel Loci Influencing Blood Pressure Response to HydrochlorothiazideErika Salvi, Zhiying Wang, Federica Rizzi, et al.Clinical Pharmacology and Therapeutics|July 7, 2021
Adverse Cardiovascular Outcomes and Antihypertensive Treatment: A Genome-Wide Interaction Meta-Analysis in the International Consortium for Antihypertensive Pharmacogenomics StudiesCaitrin W McDonough, Helen R Warren, John R Jack, et al.Neurobiology of Aging|July 9, 2015
A genome-wide screening and SNPs-to-genes approach to identify novel genetic risk factors associated with frontotemporal dementiaRaffaele Ferrari, Mario Grassi, Erika Salvi, et al.Journal of Hypertension|February 20, 2015
TET2 and CSMD1 genes affect SBP response to hydrochlorothiazide in never-treated essential hypertensivesMartina Chittani, Roberta Zaninello, Chiara Lanzani, et al.Pharmacogenomics|November 21, 2014
Genome-wide association study identifies CAMKID variants involved in blood pressure response to losartan: the SOPHIA studyFrancesca Frau, Roberta Zaninello, Erika Salvi, et al.Hypertension (Dallas, Tex. : 1979)|December 21, 2011
Genomewide association study using a high-density single nucleotide polymorphism array and case-control design identifies a novel essential hypertension susceptibility locus in the promoter region of endothelial NO synthaseErika Salvi, Zoltán Kutalik, Nicola Glorioso, et al.Pageof 4